To our knowledge, this is the first study to show that CCR4 was expressed in prostate cancer cell lines and human prostate cancer tissues and that the CCL22–CCR4 axis contributed to prostate cancer migration and invasion. The gene discussed is CCL22; the disease is prostate carcinoma.